Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions

Laboratory Investigation

Volumn 75, Issue 1, 1996, Pages 1-13

  Bolon, Isabelle ^a   Brambilla, Elisabeth ^a,c   Vandenbunder, Bernard ^b   Robert, Catherine ^a   Lantuejoul, Sylvie ^a   Brambilla, Christian ^a  

^a Institut A Bonniot   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; STROMELYSIN; TRANSCRIPTION FACTOR; UROKINASE;

ARTICLE; CARCINOMA IN SITU; CLINICAL ARTICLE; DISEASE COURSE; DYSPLASIA; ENZYME INDUCTION; ENZYME LOCALIZATION; HUMAN; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG CARCINOGENESIS; LUNG CARCINOMA; METAPLASIA; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

BRONCHIAL NEOPLASMS; CARCINOMA; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; COLLAGENASES; EXTRACELLULAR MATRIX; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LAMININ; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 11; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 7; METALLOENDOPEPTIDASES; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0029891799     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DJ, Richards WG, Sunday M, Kobzik L, and Shipp MA (1995). Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res 55:4120-4126.
2. Auerbach O, Gere JB, Forman JB, Petrick TG, Smolin HJ, Muehsam GE, Kassouny DY, and Stout AP (1957). Changes in the bronchial epithelium in relation to smoking and cancer of the lung. N Engl J Med 256:97-104.
3. Auerbach O, Hammond EC, and Garfinkel L (1979). Changes in bronchial epithelium in relation to cigarette smoking, 1955-1960 vs 1930-1977. N Engl J Med 300:381-385.
4. Auerbach O, Stout AP, Hammond EC, and Garfinkel L (1962). Changes in bronchial epithelium in relation to sex, age, residence, smoking and pneumonia. N Engl J Med 267:111-125.
5. Barsky SH, Siegal GP, Janotta F, and Liotta LA (1983). Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Invest 49:140-147.
6. Basset P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, and Chambon P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704.
7. Bolon I, Gouyer V, Devouassoux M, Vandenbunder B, Wernert N, Moro D, Brambilla C, and Brambilla E (1995). Expression of c-Ets-1, collagenase 1 and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147:1298-1310.
8. Dano K, Andreasen PA, Grondhal-Hansen J, Kristensen P, Nielsen LS, and Skriver L (1985). Plasminogen activators, tissue degradation and cancer. Adv Cancer Res 44:139-266.
9. Gaire M, Zenaida M, McDonnell S, McNeil L, Lovett DH, and Matrisian LM (1994). Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 269:2032-2040.
10. Gutman A and Wasylyk B (1990). The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. Embo J 9:2241-2246.
11. Mackay AR, Corbitt RH, Hartzler JL, and Thorgeirsson UP (1990). Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50:5997-6001.
12. Matrisian LM (1992). The matrix-degrading metalloproteinases. Bioessays 14:455-462.
13. McDonnel S, Navre M, Coffey RJ, and Matrisian LM (1991). Expression and localization of the matrix metalloproteinase pump-1 (MMP-7) in human gastric and colon carcinomas. Mol Carcinogen 4:527-533.
14. Mignati P, Robins E, and Rifkin DB (1986). Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47:487-498.
15. Mountain CF (1986). A new international staging system for lung cancer. Chest 89:225-233.
16. Muller D, Breathnach R, Engelmann A, Millon R, Bronner G, Flesh H, Dumont P, Eber M, and Abecassis J (1991). Expression of collagenase-related metalloproteinase genes in human lung or head and neck tumours. Int J Cancer 48:550-556.
17. Muller D, Quantin B, Gesnel MC, Millon-Collard R, Abecassis J, and Breathnach R (1988). The collagenase gene family in humans consists of at least four members. Biochem J 253:187-192.
18. Murphy G, Cockett ML, Ward RV, and Docherty AJP (1991). Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. Biochem J 277:277-279.
19. Nagayama M, Sato A, Hayakawa H, Urano T, Takada Y, and Takada A (1994). Plasminogen activators and their inhibitors in non-small cell lung cancer. Cancer 73:1398-1405.
20. Nerlov C, Rorth P, Blasi F, and Johnsen M (1991). Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. Oncogene 6:1583-1592.
21. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, and Chambon P (1990). Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP-1 binding site. EMBO J 9:4443-4454.
22. Oka T, Ishida T, Nishino T, and Sugimachi K (1991). Immunohistochemical evidence of urokinase-type plasminogen activator in primary and metastatic tumors of pulmonary adenocarcinoma. Cancer Res 51:3522-3525.
23. Pei D, Majmudar G, and Weiss SJ (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem 269:25849-25855.
24. Peters EJ, Morice M, Benner SE, Lippman S, Lukeman J, Lee JS, Ro JY, and Hong WK (1993). Squamous metaplasia of the bronchial mucosa and its relationship to smoking. Chest 103:1429-1432.
25. Quinones S, Sans J, Otari Y, Harris EDJ, and Kurkinen M (1989). Transcriptional regulation of human stromelysin. J Biol Chem 264:8339-8344.
26. Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller JC, and Miskin R (1988). Effects of inhibitors of plasminogen activators, serine proteinases, and collagenase IV on the invasion of basement membrane by metastatic cells. Cancer Res 48:3307-3312.
27. Rouyer N, Wolf C, Chenard MP, Rio MC, Chambon P, Bellocq JP, and Basset P (1994). Stromelysin-3 gene expression in human cancer: An overview. Invas Metast 14:269-275.
28. Santavicca M, Noel A, Chenard MP, Lutz Y, Stoll I, Segain JP, Rouyer N, Rio MC, Wolf C, Bellocq JP, and Basset P (in press). Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry. Int J Cancer.
29. Schüle R, Rangarajan P, Yang N, Kliewer S, Ransone LJ, Bolado J, Verma IM, and Evans RM (1991). Retinoic acid is a negative regulator of AP-1 -responsive genes. Proc Natl Acad Sci USA 88:6092-6096.
30. Sires UI, Griffin GL, Broekelmann TJ, Mecham RP, Murphy G, Chung AE, Welgus HG, and Senior RM (1993). Degradation of entactin by matrix metalloproteinases. J Biol Chem 268: 2069-2074.
31. Solomon MD, Greenberg SD, and Spjut HJ (1990). Morphology of bronchial epithelium adjacent to adenocarcinoma of the lung. Mod Pathol 3:684-687.
32. Stacey KJ, Fowles LF, Colman MS, Ostrowski MC, and Hume DA (1995). Regulation of urokinase-type plasminogen activator gene transcription by macrophage colony-stimulating factor. Mol Cell Biol 15:3430-3441.
33. Trump BF, Mc Dowell EM, Glaxin F, Barret LA, Becci PJ, Schürch W, Kaiser HE, and Harris CC (1978). The respiratory epithelium. III. Histogenesis of epidermoid metaplasia and carcinoma in situ in the human. J Natl Cancer Inst 61:563-575.
34. Urbanski SJ, Edwards DR, Maitland A, Leco KJ, Watson A, and Kossakowska AE (1992). Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Br J Cancer 66:1188-1194.
35. Vandenbunder B, Pardanaud L, Jaffredo T, Mirabel MA, and Stéhelin D (1989). Complementary patterns of expression of c-Ets-1, c-myb and c-myc in the blood forming system of the chick embryo. Development 107:265-274.
36. Wasylyk C, Gutman A, Nicholson R, and Wasylyk B (1991). The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 10:1127-1134.
37. Wasylyk C and Wasylyk B (1992). Oncogenic conversion alters the transcriptional properties of Ets. Cell Growth Differ 3:617-625.
38. Wernert N, Gilles F, Fafeur V, Bouali F, Raes MB, Pyke C, Dupressoir T, Seitz G, Vandenbunder B, and Stéhelin D (1994). Stromal expression of c-Ets-1 transcription factor correlates with tumor invasion. Cancer Res 54:5683-5688.
39. Wernert N, Raes MB, Lassalle PH, Dehouck MP, Gosselin B, Vandenbunder B, and Stéhelin D (1992). c-Ets-1 protooncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 140:119-127.
40. Wolf C, Rouyer N, Lutz Y, Adida C, Loriot M, Bellocq JP, Chambon P, and Basset P (1993). Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression. Proc Natl Acad Sci USA 90:1843-1847.
41. Yoneda K and Boucher LD (1993). Bronchial epithelial changes associated with small cell lung carcinoma of the lung. Hum Pathol 24:1180-1183.